Tags

Type your tag names separated by a space and hit enter

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Links

  • Publisher Full Text
  • Authors

    , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

    Source

    Circulation 129:25 Suppl 2 2014 Jun 24 pg S1-45

    MeSH

    American Heart Association
    Anticholesteremic Agents
    Atherosclerosis
    Humans
    Hypercholesterolemia
    Primary Prevention
    Risk Factors
    Secondary Prevention
    United States

    Pub Type(s)

    Journal Article
    Practice Guideline

    Language

    eng

    PubMed ID

    24222016

    Citation

    Stone, Neil J., et al. "2013 ACC/AHA Guideline On the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines." Circulation, vol. 129, no. 25 Suppl 2, 2014, pp. S1-45.
    Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1-45.
    Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., ... Tomaselli, G. F. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(25 Suppl 2), pp. S1-45. doi:10.1161/01.cir.0000437738.63853.7a.
    Stone NJ, et al. 2013 ACC/AHA Guideline On the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. PubMed PMID: 24222016.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. AU - Stone,Neil J, AU - Robinson,Jennifer G, AU - Lichtenstein,Alice H, AU - Bairey Merz,C Noel, AU - Blum,Conrad B, AU - Eckel,Robert H, AU - Goldberg,Anne C, AU - Gordon,David, AU - Levy,Daniel, AU - Lloyd-Jones,Donald M, AU - McBride,Patrick, AU - Schwartz,J Sanford, AU - Shero,Susan T, AU - Smith,Sidney C,Jr AU - Watson,Karol, AU - Wilson,Peter W F, AU - Eddleman,Karen M, AU - Jarrett,Nicole M, AU - LaBresh,Ken, AU - Nevo,Lev, AU - Wnek,Janusz, AU - Anderson,Jeffrey L, AU - Halperin,Jonathan L, AU - Albert,Nancy M, AU - Bozkurt,Biykem, AU - Brindis,Ralph G, AU - Curtis,Lesley H, AU - DeMets,David, AU - Hochman,Judith S, AU - Kovacs,Richard J, AU - Ohman,E Magnus, AU - Pressler,Susan J, AU - Sellke,Frank W, AU - Shen,Win-Kuang, AU - Smith,Sidney C,Jr AU - Tomaselli,Gordon F, AU - ,, Y1 - 2013/11/12/ PY - 2013/11/14/entrez PY - 2013/11/14/pubmed PY - 2014/10/1/medline KW - AHA Scientific Statements KW - biomarkers, pharmacological KW - cardiovascular disease KW - cholesterol KW - diabetes mellitus KW - drug therapy KW - hydroxymethylglutaryl-CoA reductase inhibitors/statins KW - hypercholesterolemia KW - lipids KW - patient compliance KW - primary prevention KW - risk assessment KW - risk reduction behavior KW - secondary prevention SP - S1 EP - 45 JF - Circulation JO - Circulation VL - 129 IS - 25 Suppl 2 SN - 1524-4539 UR - https://www.unboundmedicine.com/medline/citation/24222016/full_citation L2 - http://www.ahajournals.org/doi/full/10.1161/01.cir.0000437738.63853.7a?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -